Price is the Main Barrier to Wider Use of Papillomavirus Vaccine

At its debut 2 years ago, a vaccine that pre-vents cervical cancer was heralded as a public health breakthrough that could poten-tially save millions of women’s lives. Yet although the vaccine is now given routinely to young girls in the United States and Europe, it hasn’t been deployed in poorer countries, where it could make a bigger difference.


Expertos piden acceso a mejoras en detección y tratamiento del cáncer cervicouterino, junto con vacunas a precios más asequibles

May 14, 2008 | La Segunda 

Expertos en vacunación y cáncer cervical hoy pidieron apoyar el desarrollo de programas integrados y apoyo para prevenir y controlar cáncer cervical, una de las principales causas de mortalidad en mujeres de América Latina y el Caribe.

La Segunda

Toward Comprehensive Cervical Cancer Prevention and Control (Region of the Americas)

12 - 13 May 2008
Public Health officials from throughout the Americas gathered with immunization and disease experts May 12-13, 2008 in Mexico City to discuss new approaches to fighting cervical cancer in the region. “Toward Comprehensive Cervical Cancer Prevention and Control in the Region of the Americas” was hosted by the Sabin Vaccine Institute, the World Health Organization (WHO), the Pan American Health Organization (PAHO), and the US Centers for Disease Control and Prevention (CDC).